CIK 0001819576
- Non-accelerated filer
Liquidia Corp
Sign in to watch- Ticker
- LQDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851710962
- Phone
- +1 919-328-4400
- Business address
- 419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC, 27560
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,616,882
- in 14 filings, $3.0M under 10b5-1 plans
Net −$10,616,882. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 97 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-20 | JOHNSON DAVID EDWARD Director | Grant or award | +20,359 | 20,359 | ||
| 2024-06-20 | Horobin Joanna Director | Grant or award | +20,359 | 20,359 | ||
| 2024-06-20 | deGoa Damian Director | Grant or award | +20,359 | 68,075 | ||
| 2024-06-20 | Bloch Stephen M Director | Grant or award | +20,359 | 20,359 | ||
| 2024-06-03 | Kaseta Michael CFO and COO | Sale 10b5-1 | −1,094 | $14.55 | $16K | 316,295 |
| 2024-06-03 | Adair Jason Chief Business Officer | Sale 10b5-1 | −455 | $14.55 | $7K | 112,465 |
| 2024-06-03 | Schundler Russell General Counsel | Sale 10b5-1 | −710 | $14.55 | $10K | 487,661 |
| 2024-06-03 | Moomaw Scott Chief Commercial Officer | Sale 10b5-1 | −546 | $14.55 | $8K | 153,210 |
| 2024-05-31 | Kaseta Michael CFO and COO | Exercise or conversion 10b5-1 | +2,344 | 317,389 | ||
| 2024-05-31 | Kaseta Michael CFO and COO | Exercise or conversion · Restricted Stock Unit 10b5-1 | −2,344 | 16,406 | ||
| 2024-05-31 | Adair Jason Chief Business Officer | Exercise or conversion 10b5-1 | +1,563 | 112,920 | ||
| 2024-05-31 | Adair Jason Chief Business Officer | Exercise or conversion · Restricted Stock Unit 10b5-1 | −1,563 | 10,937 | ||
| 2024-05-31 | Schundler Russell General Counsel | Exercise or conversion 10b5-1 | +2,344 | 488,371 | ||
| 2024-05-31 | Schundler Russell General Counsel | Exercise or conversion · Restricted Stock Unit 10b5-1 | −2,344 | 16,406 | ||
| 2024-05-31 | Moomaw Scott Chief Commercial Officer | Exercise or conversion 10b5-1 | +1,875 | 153,756 | ||
| 2024-05-31 | Moomaw Scott Chief Commercial Officer | Exercise or conversion · Restricted Stock Unit 10b5-1 | −1,875 | 13,125 | ||
| 2024-04-19 | Saggar Rajeev Chief Medical Officer | Sale 10b5-1 | −1,649 | $13.68 | $23K | 211,672 |
| 2024-04-12 | Schundler Russell General Counsel | Sale 10b5-1 | −2,060 | $14.58 | $30K | 486,027 |
| 2024-04-12 | Saggar Rajeev Chief Medical Officer | Sale 10b5-1 | −1,525 | $14.58 | $22K | 213,321 |
| 2024-04-12 | Moomaw Scott Chief Commercial Officer | Sale 10b5-1 | −1,585 | $14.58 | $23K | 151,881 |
Page 32 of 39 · 771 trades